AMA joins AllTrials campaign for clinical trial transparency

Today the American Medical Association (AMA) joins more than 640 patient advocacy groups, professional societies, medical organizations and thousands of patients worldwide in supporting the global campaign for clinical trial registration and reporting led by AllTrials.

"The AMA strongly supports improving the timeliness and accessibility of clinical trial data to reduce the duplication of research and help inform future research — ultimately improving health outcomes for patients," said AMA President Steven. J. Stack. "The AMA is pleased to join the AllTrials initiative to continue efforts aimed at ensuring open access to clinical trial data for physicians, researchers and patients."